Metraipolis › archive › dc_197de72ab155

Infectious adverse events associated with immune checkpoint inhibitors: a pharmacovigilance analysis based on FAERS database — Europe PMC PMID:41208964

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41208964
DOI: 10.3389/fimmu.2025.1647944
License (as archived): solo-consultazione
Archived: 2026-11-09T02:47:35.893Z
SHA-256 of the archived text: 9577de8072196e83074a5dadbba9c552d80d1eeb917c166c498e8cf6663c618f
Stable URL of this page: https://metraipolis.com/documento/dc_197de72ab155

How to cite

Infectious adverse events associated with immune checkpoint inhibitors: a pharmacovigilance analysis based on FAERS database — Europe PMC PMID:41208964 — Europe PMC (en), https://europepmc.org/article/MED/41208964 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_197de72ab155 (Metraipolis archive dc_197de72ab155, sha256 9577de8072196e83074a5dadbba9c552d80d1eeb917c166c498e8cf6663c618f)

BibTeX

@misc{dc197de72ab155,
  title = {Infectious adverse events associated with immune checkpoint inhibitors: a pharmacovigilance analysis based on FAERS database — Europe PMC PMID:41208964},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41208964},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_197de72ab155; sha256 9577de8072196e83074a5dadbba9c552d80d1eeb917c166c498e8cf6663c618f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41208964. Agents can read the archived copy with the MCP tool read_document.